Inscription Capital’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.79M Sell
17,276
-1,216
-7% -$109K 0.16% 113
2026
Q1
$1.33M Buy
18,492
+306
+2% +$23.6K 0.14% 131
2025
Q4
$1.44M Sell
18,186
-718
-4% -$56.6K 0.15% 111
2025
Q3
$1.43M Buy
18,904
+11,332
+150% +$777K 0.15% 106
2025
Q2
$522K Buy
+7,572
New +$497K 0.08% 193
2021
Q3
Sell
-25,674
Closed -$2.14M 245
2021
Q2
$2.14M Buy
+25,674
New +$2.1M 0.24% 85

Other funds holding CVS

Inscription Capital's CVS Position: Q2 2026 in Review

Inscription Capital reduced its CVS Health (CVS) stake by 6.6% in Q2 2026, selling an estimated $109K and leaving 17,276 shares worth $1.79M. The position accounts for 0.16% of the portfolio, ranked #113.

Inscription Capital first reported a position in CVS in Q2 2021 and has held it in 6 quarters since. The position peaked at $2.14M in Q2 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Inscription Capital held 17,276 shares of CVS Health worth $1.79M as of Q2 2026.
  • Inscription Capital sold 1,216 CVS Health shares in Q2 2026, an estimated $109K.
  • CVS Health made up 0.16% of Inscription Capital's portfolio in Q2 2026, its #113 holding.
  • Inscription Capital first reported a position in CVS Health in Q2 2021 and has held it in 6 quarters since.
  • Inscription Capital's CVS Health position peaked at $2.14M in Q2 2021.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.